ENPP3

ENPP3 분자 정보

영어 이름Ectonucleotide pyrophosphatase/phosphodiesterase family member 3시판 약물 수0
임상 약물 수4표적 별명EC:3.1.4.1,E-NPP 3,PD-Ibeta,NPPase,CD203c,PDNP3,Phosphodiesterase I/nucleotide pyrophosphatase 3,Nucleotide diphosphatase,ENPP3,DJ914N13.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),Phosphodiesterase-I Beta,Phosphodiesterase I Beta,CD203c Antigen,Gp130RB13-6,NPP3,B10,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3,Ectonucleotide Pyrophosphatase/Phosphodiesterase 3,DJ1005H11.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),EC:3.6.1.9
최고 연구 개발 단계Phase 1 Clinical
영어 이름Ectonucleotide pyrophosphatase/phosphodiesterase family member 3
표적 별명EC:3.1.4.1,E-NPP 3,PD-Ibeta,NPPase,CD203c,PDNP3,Phosphodiesterase I/nucleotide pyrophosphatase 3,Nucleotide diphosphatase,ENPP3,DJ914N13.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),Phosphodiesterase-I Beta,Phosphodiesterase I Beta,CD203c Antigen,Gp130RB13-6,NPP3,B10,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3,Ectonucleotide Pyrophosphatase/Phosphodiesterase 3,DJ1005H11.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),EC:3.6.1.9
시판 약물 수0
임상 약물 수4
최고 연구 개발 단계Phase 1 Clinical

ENPP3분자 배경

The human NPP family contains seven members which can be classified into two groups according to their substrate preferences. The first class comprises the nucleotide-degrading proteins NPP1, 3 and 4. NPP3 (CD203c, ENPP3) is expressed in multiple organs, including on epithelial and mucosal surfaces, and notably on basophils and mast cells. Activation of basophils by antigen-bound IgE leads to release of inflammatory mediators and rapid upregulation of NPP3 to the cell surface. This protein is in fact a common marker for diagnosing allergen sensitivity with patient basophils by flow cytometry. Basophils and mast cells mediate the response to certain pathogens, as well as acute and chronic allergic reactions. Following activation, these cells release ATP, which further stimulates them in an autocrine manner. NPP3 upregulation serves to degrade ATP and suppress chronic allergic inflammation (but not the acute response).

ENPP3분자 별명

ENPP3,CD203c,NPP3,E-NPP3,PD-Ibeta,NPPase,PDNP3

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
XmAb-819XmAb-819Phase 1 ClinicalXencor IncCarcinoma, Renal Cell; Kidney Neoplasms
상세
JNJ-89862175JNJ-89862175Phase 1 ClinicalJanssen Research & Development LlcSolid tumours
상세
ALY-301ALY-301; GTX-B001Phase 1 ClinicalAlys Pharmaceuticals IncChronic Urticaria; Symptomatic Dermographism; Urticaria
상세
JNJ-87890387JNJ-87890387Phase 1 ClinicalJanssen Research & Development LlcNeoplasms; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호